Dr. McMeekin is the Virginia Kerley Cade Chair in Cancer Developmental Therapeutics, and Deputy Director for Clinical Research at the Stephenson Cancer Center at the University of Oklahoma. He serves as a Presbyterian Foundation Presidential Professor at the University of Oklahoma in the Section of Gynecologic Oncology. He received his MD from the Loyola University, Stritch School of Medicine in 1990. He completed his residency in Obstetrics and Gynecology at UC Irvine in 1994, and continued at UCI to complete a fellowship in Gynecologic Oncology in 1998. Since 1998, Dr. McMeekin has been on the Obstetrics and Gynecology faculty at the University of Oklahoma. He was named Fellowship Director in 2003 and Section Chief in 2006. He has served the GOG on the Gynecologic Oncology, Uterine Corpus, and Developmental Therapeutics committees. He currently sits on the GOG Board of Directors and serves as Secretary of the Board. He has been an invited speaker at Foundation for Women’s Cancer meetings and hosted the first endometrial cancer survivorship course in Oklahoma City.
“As FWC enters its 25th year of serving women diagnosed with a gynecologic cancer and those who are at risk, this merger will consolidate all FWC activities for the benefit of our Society and women,” said David. G Mutch, MD, who will serve as Chair of the new FWC.